This inventor holds 14 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent. Top assignees: American Infertility of New York, Women's Lab Company, LLC, Other. Active years: 2009-2021.
Company Filing History:
7 out of 7 
1 out of 1 
7 out of 834,411 Years Active: 2009-2021
Title: David H Barad: Innovator in Infertility Treatment
Introduction:
Throughout his career, David H Barad, a resident of Closter, NJ (US), has made significant contributions to the field of infertility treatment. His groundbreaking work in diagnosing and administering anti-Mullerian hormone (AMH) for in vitro fertilization (IVF) has garnered him recognition and numerous patents. This article highlights Barad's latest patents, career achievements, and collaborations.
Latest Patents:
One of David H Barad's latest patents is the "Diagnosis and Anti-Mullerian Hormone (AMH) Administration for Treatment of Infertility for Good-, Intermediate-, and Poor-Prognosis Patients for In Vitro Fertilization in View of Logistic Regression Models - Method of Diagnosis of IVF Viability." This patent outlines a method for determining a subject's AMH level through testing and selecting the appropriate pregnancy or live birth prognosis category based on age-specific ranges of AMH levels. Consequently, tailored administrations of AMH can be pursued to increase the probability of pregnancy or live birth.
Career Highlights:
Barad's career is characterized by a dedication to advancing infertility treatment. With fourteen patents to his name, he has significantly contributed to the field. His expertise lies in developing diagnostic methods and administering AMH treatment for optimizing IVF success. Barad's research has revolutionized reproductive medicine, helping individuals and couples fulfill their dreams of parenthood.
Collaborations:
Throughout his career, Barad has had the opportunity to work with esteemed colleagues and experts in the field. Notable collaborations include partnerships with Norbert Gleicher and Dwyn V Harben. These collaborative efforts have contributed to the advancement of infertility treatments and have resulted in several breakthroughs.
Conclusion:
David H Barad's innovative contributions to infertility treatment have shaped the field of reproductive medicine. His patents demonstrate cutting-edge methods for diagnosing and administering AMH treatment in IVF procedures. Through his collaborations and dedication to advancing the field, Barad has left a lasting impact on the lives of countless individuals and families struggling with infertility. As we continue to witness advancements in this area, it is clear that Barad's work has paved the way for more effective and personalized infertility treatments in the future.
Note: The information provided in this article has been formulated based on the details given and may not necessarily reflect the most up-to-date or complete information about David H Barad and his career. For the latest and most accurate information, it is recommended to refer to official sources or contact relevant authorities or organizations.